News

Video

ASCRS 2025: Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications

The retrospective study assessed corneal cross-linking complications at Wills Eye Hospital from 2018 to 2023.

At the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Los Angeles, California, the Eye Care Network met with Weijie Violet Lin, MD, ABO. An assistant professor at the Weill Cornell department of ophthalmology in New York, Dr. Lin was previously a cornea fellow at Wills Eye Hospital in Philadelphia, Pennsylvania.

Her presentation focused on a study of cross-linking complications at Wills Eye Hospital over a 5-year time period, ranging from 2018 to 2023. The research focused on persistent epithelial defects, corneal haze, and infiltrates.

Dr. Lin shared findings about the complications, including assessments of socioeconomic factors and their impact on patient outcomes. She also highlighted applicable clinical insights from the research, such as pearls for prioritizing patients with specific risk factors. "For some of those patients that do have these factors that we're seeing are more likely to be associated with development of complications, I would consider putting those patients first in the line for epi-on crosslinking when it becomes available," Dr. Lin advised.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
© 2025 MJH Life Sciences

All rights reserved.